Target intelligence / Profile preview

AL021408.2 (ENSG00000280155)

Target
ENSG00000280155
Molecular classification
Other
01

Overview

The gene designated by ENSG00000280155 (also known as AL021408.2) is catalogued in human genome databases and is reported to be expressed in the testis and several other cell types. However, there is no functional annotation, disease association, or experimental evidence indicating it encodes a protein or plays a notable role in human physiology or disease. It is not recognized as a therapeutic target, and its biomedical relevance appears minimal or unexplored at present[5].

Other names
ENSG00000280155AL021408.2

Beyond the preview

Go deeper on AL021408.2 (ENSG00000280155).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AL021408.2 (ENSG00000280155).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call